Please consider submitting your work to Experimental and Clinical Psychopharmacology. More information about the journal is below.
Experimental and Clinical Psychopharmacology
Our goal is to improve the quality and speed of the review process, as well as the quality and breadth of manuscripts published in Experimental and Clinical Psychopharmacology. Here are some of the reasons why you, your colleagues, trainees and students should submit your research to Experimental and Clinical Psychopharmacology:
· Rapid Turnaround: The average speed from submission to initial decision letter is 21 days
· Impact Factor: The 2014 impact factor was 2.712 compared to 2.626 in 2013
· Favorable Rate of Acceptance: Approximately 40-50% of manuscripts submitted are accepted
· No Set Page Restrictions: There is no a priori limit on the number of words, tables, figures or references, but manuscript length should be reasonable given the nature of the study and findings.
Experimental and Clinical Psychopharmacology (ECP) publishes advances in translational and interdisciplinary research on psychopharmacology and drug abuse. The scope of research in these areas continues to expand and to benefit from collaborations across a broad range of disciplines, including behavioral science, brain imaging, genetics, neuroendocrinology, neuroscience, and pharmacology. One goal of the journal is to encourage increased attention to biologic factors that may influence both the pharmacodynamic and the pharmacokinetic effects of drugs. Recent research has shown the importance of examining the effects of sex and menstrual/estrous cycle phase on the effects of abused drugs, as well as responses to medications for the treatment of drug abuse and the alleviation of pain. The journal publishes original reports on the development and evaluation of new pharmacotherapies, the influence of genetics and hormones on responses to abused drugs and treatment medications, the pharmacological management of pain, and brain imaging studies of the neural correlates of drug effects. The journal will focus on clinical laboratory studies and controlled clinical medication trials as well as basic preclinical experiments on psychopharmacology and drug abuse. The journal also will include comprehensive and integrative reviews of advances in research on psychopharmacology. These reviews should provide a broad perspective on a particular area of research or trace the development of critical concepts and experimental approaches.
Submit your manuscripts to:
William W. Stoops, Ph.D.
phone: (859) 257-5383
facsimile: (859) 257-7684
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science
STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.